Skip to content
Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
The FDA’s Accelerated Approval pathway has assisted America’s biotech industry in making remarkable advances over the last 30 years—but it has come under political […]
Accelerated Approval is under political attack, experts say Read More »
On April 13, the U.S. Food and Drug Administration (FDA) released new draft guidance for industry on “creating strategies to recruit additional participants from underrepresented
BIO recommends improvements to FDA’s clinical trial diversity guidance Read More »
On June 22, the Senate Commerce Committee approved BIO-supported legislation intended to increase transparency of the business practices of pharmacy benefit managers (PBMs), which
Senate Committee advances PBM transparency legislation Read More »
The Biotechnology Innovation Organization (BIO) is proud to celebrate Pride Month, which, in many places, is returning to in-person celebrations for the first time
Pride Month is back in person – here’s how biotech is celebrating Read More »
The World Trade Organization (WTO) agreed to waive COVID vaccine intellectual property protections—and many stakeholders are upset about it. Yes, the COVID vaccine IP
The COVID vaccine IP waiver is not a good idea – here’s why Read More »
We can support the development of biotechnology that reduces the environmental footprint of chemical manufacturing by correctly defining sustainable chemistry, states the Biotechnology Innovation
What is ‘sustainable chemistry’? BIO answers. Read More »
The World Trade Organization (WTO) agreed to “a waiver of certain requirements concerning compulsory licensing for COVID-19 vaccines.” However, the waiver of COVID vaccine
WTO agrees to COVID vaccine IP waiver – here’s what we know Read More »
Remarks from Paul Hastings, CEO of Nkarta Therapeutics and Chairman of the Biotechnology Innovation Organization (BIO), as prepared for delivery at the BIO International
The COVID-19 pandemic brought anxiety and uncertainty worldwide, and also created challenges from social isolation to supply chain issues to economic instability, which worsened
BIO Unbound: ‘Science is limitless when we limit science less’ Read More »
On Day 2, the Good Day BIO Live team brings you exclusive interviews with Johnson & Johnson’s Pierre Theodore, Travere Therapeutics’ Eric Dube, Organon’s Kevin Ali,
Good Day BIO LIVE! from San Diego – watch Tuesday’s episode Read More »
